Oragenics Inc. (OGEN) financial statements (2021 and earlier)

Company profile

Business Address 4902 EISENHOWER BLVD
TAMPA, FL 33634
State of Incorp. FL
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18182064510
Cash and cash equivalents18182064510
Receivables     00
Inventory, net of allowances, customer advances and progress billings     00
Inventory     00
Other undisclosed current assets0121000
Total current assets:18192274611
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment0000000
Total noncurrent assets:1100000
TOTAL ASSETS:19202274611
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1211111
Accounts payable0111000
Accrued liabilities0000000
Employee-related liabilities0000000
Other undisclosed accounts payable and accrued liabilities0000100
Debt0000000
Deferred compensation liability      0
Due to related parties      0
Deferred revenue and credits  00
Other undisclosed current liabilities0     (0)
Total current liabilities:1211111
Noncurrent Liabilities
Long-term debt and lease obligation01     
Operating lease, liability01
Other undisclosed noncurrent liabilities(0)      
Total noncurrent liabilities:01     
Total liabilities:2311111
Stockholders' equity
Stockholders' equity attributable to parent17172163510
Preferred stock7766   
Common stock0000000
Common stock, share subscribed but unissued, subscriptions receivable    (0)  
Additional paid in capital164138126101989286
Accumulated deficit(154)(127)(111)(101)(95)(88)(76)
Total stockholders' equity:17172163510
TOTAL LIABILITIES AND EQUITY:19202274611

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues     11
Revenue, net  1 
Cost of revenue
(Cost of Goods and Services Sold)
     (0)(0)
Gross profit:     11
Operating expenses(27)(16)(10)(7)(9)(12)(6)
Operating loss:(27)(16)(10)(7)(9)(12)(6)
Nonoperating income (expense)000(0)0(0)0
Investment income, nonoperating0000000
Other nonoperating income (expense)000000(0)
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(26)(16)(10)(7)(9)(12)(6)
Other undisclosed income from continuing operations before income taxes0000000
Loss from continuing operations before income taxes:(26)(16)(10)(7)(8)(12)(6)
Income tax expense (benefit)(6)(4)(2)10342
Income (loss) from continuing operations:(33)(19)(12)3(6)(7)(4)
Income from discontinued operations    1  
Net income (loss):(33)(19)(12)3(4)(7)(4)
Other undisclosed net income (loss) attributable to parent642(10)(3)(4)(2)
Net loss attributable to parent:(26)(16)(10)(7)(7)(12)(6)
Other undisclosed net loss available to common stockholders, basic  (1)    
Net loss available to common stockholders, diluted:(26)(16)(11)(7)(7)(12)(6)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(33)(19)(12)3(4)(7)(4)
Comprehensive income (loss), net of tax, attributable to parent:(33)(19)(12)3(4)(7)(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: